Abstract
Functional sensitization and structural plasticity in the nociceptive pathways and modulatory networks in the peripheral and central nervous system develop following tissue and nerve injury and result in persistent or chronic pain, a major challenge to clinical management. Development of novel analgesic drugs requires a better understanding of the molecular and cellular mechanisms underlying persistent pain. Research during the last three decades has focused on the involvement of neuronal mechanisms in persistent pain. Recently accumulating evidence indicates that reactive glial cells play a critical role in peripheral and central sensitization during the development of persistent pain in variety of animal pain models. The purpose of this review is to highlight important recent advances in astrocytic mechanisms in experimentally persistent pain and the potential to use this information to develop new drugs targeting astrocytic signaling in the treatment of pathological pain.
Keywords: Astrocyte, signal transduction, proinflammatory cytokines, neronal plasticity, pain, analgesic drugs, tissue injury, astrocytic signaling, CNS, peripheral sensitization
Current Signal Transduction Therapy
Title: Astrocytic Signaling in Persistent Pain
Volume: 7 Issue: 1
Author(s): Yu-Xia Chu, Zhi-Qi Zhao and Feng Wei
Affiliation:
Keywords: Astrocyte, signal transduction, proinflammatory cytokines, neronal plasticity, pain, analgesic drugs, tissue injury, astrocytic signaling, CNS, peripheral sensitization
Abstract: Functional sensitization and structural plasticity in the nociceptive pathways and modulatory networks in the peripheral and central nervous system develop following tissue and nerve injury and result in persistent or chronic pain, a major challenge to clinical management. Development of novel analgesic drugs requires a better understanding of the molecular and cellular mechanisms underlying persistent pain. Research during the last three decades has focused on the involvement of neuronal mechanisms in persistent pain. Recently accumulating evidence indicates that reactive glial cells play a critical role in peripheral and central sensitization during the development of persistent pain in variety of animal pain models. The purpose of this review is to highlight important recent advances in astrocytic mechanisms in experimentally persistent pain and the potential to use this information to develop new drugs targeting astrocytic signaling in the treatment of pathological pain.
Export Options
About this article
Cite this article as:
Chu Yu-Xia, Zhao Zhi-Qi and Wei Feng, Astrocytic Signaling in Persistent Pain, Current Signal Transduction Therapy 2012; 7 (1) . https://dx.doi.org/10.2174/157436212799278052
DOI https://dx.doi.org/10.2174/157436212799278052 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Control of Male Sexual Responses
Current Pharmaceutical Design Gelatin-Siloxane Hybrid Scaffolds with Vascular Endothelial Growth Factor Induces Brain Tissue Regeneration
Current Neurovascular Research Systematic Review of Preclinical and Clinical Studies on Scaffold Use in Knee Ligament Regeneration
Current Stem Cell Research & Therapy Preclinical Analyses of the Therapeutic Potential of Allopregnanolone to Promote Neurogenesis In Vitro and In Vivo in Transgenic Mouse Model of Alzheimers Disease
Current Alzheimer Research Benzimidazole Derivative Ameliorates Opioid-Mediated Tolerance during Anticancer- Induced Neuropathic Pain in Mice
Anti-Cancer Agents in Medicinal Chemistry Protein Kinase CK2 in Human Diseases
Current Medicinal Chemistry Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke Treatment
Current Pharmaceutical Design Implication for Thiazolidinediones (TZDs) as Novel Potential Anti- Inflammatory Drugs
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Impact of Cardiovascular Diseases on Cardiovascular Regulation During Exercise in Humans: Studies on Metaboreflex Activation Elicited by the Post-exercise Muscle Ischemia Method
Current Cardiology Reviews Inhibition of Rho/Rho-Kinase as Therapeutic Strategy to Promote CNS Axonal Regeneration
Central Nervous System Agents in Medicinal Chemistry Recent updates on the dynamic association between oxidative stress and neurodegenerative disorders
CNS & Neurological Disorders - Drug Targets Revision on Renal Sympathetic Ablation in the Treatment of Resistant Hypertension
Current Hypertension Reviews Experimental Research on Nitric Oxide and the Therapy of Alzheimer Disease: A Challenging Bridge
CNS & Neurological Disorders - Drug Targets Quantitative Gait Disturbances in Older Adults with Cognitive Impairments
Current Pharmaceutical Design Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs
Current Medicinal Chemistry Wnt1 Inducible Signaling Pathway Protein 1 (WISP1) Blocks Neurodegeneration through Phosphoinositide 3 Kinase/Akt1 and Apoptotic Mitochondrial Signaling Involving Bad, Bax, Bim, and Bcl-xL
Current Neurovascular Research Patent Selections:
Recent Patents on Regenerative Medicine Drugs and Aggression
Recent Patents on CNS Drug Discovery (Discontinued) Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases
Current Pharmaceutical Design Immune Mechanisms and Novel Pharmacological Therapies of Acute Kidney Injury
Current Drug Targets